Skip to content

Public FDA record

Z-2382-2021: EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128

Recall record Z-2382-2021 for Thera Test Laboratories, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2382-2021
Company in FDA record
Thera Test Laboratories, Inc.
FDA record creation date
Aug 27, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128

Source facts

Action
The firm initiated the recall using undated letters attached to emails sent on 10/7/2020 requesting return of product.
Initiated
2020-10-05
Root cause
No Marketing Application
Terminated
2022-02-15
Distribution
US Nationwide distribution in the states of California, Florida, Illinois, Indiana, North Carolina, and Texas.
Recall number
Z-2382-2021
Recall status
Terminated
CDRH record ID
188755
FDA record created
2021-08-27
Recall event number
88478

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗